Galactose-modified duocarmycin prodrugs as senolytics (2020)
Attributed to:
Molecular and Cellular Mechanisms Underlying Pituitary Tumours
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/acel.13133
PubMed Identifier: 32175667
Publication URI: http://europepmc.org/abstract/MED/32175667
Type: Journal Article/Review
Parent Publication: Aging Cell
Issue: 4
ISSN: 1474-9718